The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.

På svenska

Author

Publishing year

2006

Language

English

Pages

189-196

Publication/Series

BJU International

Volume

98

Issue

1

Document type

Journal article

Publisher

Wiley-Blackwell

Topic

  • Urology and Nephrology

Keywords

  • Research Support
  • Aged
  • Prostatic Neoplasms: pathology
  • Non-U.S. Gov't
  • Cell Transformation
  • Prostatic Neoplasms: metabolism
  • Chromogranins: metabolism
  • Cystatins: metabolism
  • Disease Progression
  • Humans
  • Ki-67 Antigen: metabolism
  • Male
  • Middle Aged
  • Neuroendocrine Tumors: metabolism
  • Neuroendocrine Tumors: pathology
  • Neoplastic

Status

Published

Research group

  • Urological cancer, Malmö
  • Clinical Chemistry, Malmö

ISBN/ISSN/Other

  • ISSN: 1464-4096